Pharmaceutical firm Catalent buys government-backed facility near Oxford
The US-headquartered pharmaceutical company Catalent has bought Vaccine Manufacturing and Innovation Centre (VMIC) that is under construction in Oxfordshire, UK. The government-supported facility was intended to be the country’s first non-profit vaccine producer. Catalent plans to invest £120 million to finish building the centre, which is expected to employ more than 400 people when it eventually opens.